Supernus Pharmaceuticals Inc (SUPN)

Jul 25, 2025

What analysts say about Supernus Pharmaceuticals Inc. stockRapid wealth creation - Autocar Professional

Jul 25, 2025

Jul 24, 2025

What institutions are buying Supernus Pharmaceuticals Inc. stock nowBreakthrough stock performance - jammulinksnews.com

Jul 24, 2025

Jul 24, 2025

Branded Pharmaceuticals Stocks Q1 Recap: Benchmarking Supernus Pharmaceuticals (NASDAQ:SUPN) - FinancialContent

Jul 24, 2025

Jul 24, 2025

What makes Supernus Pharmaceuticals Inc. stock attractive to long term investorsBreakout portfolio performance - jammulinksnews.com

Jul 24, 2025

Jul 23, 2025

Is Supernus Pharmaceuticals Inc. a good long term investmentExtraordinary performance - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Supernus Pharmaceuticals Inc. Stock Analysis and ForecastStrong return on investment - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Benign Growth For Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Underpins Its Share Price - simplywall.st

Jul 23, 2025

Jul 23, 2025

Published on: 2025-07-23 12:28:32 - Autocar Professional

Jul 23, 2025

Jul 22, 2025

Supernus Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 5 - Quiver Quantitative

Jul 22, 2025

Jul 22, 2025

Supernus Pharmaceuticals to Announce Second Quarter 2025 - GlobeNewswire

Jul 22, 2025

Jul 22, 2025

SUPN SEC FilingsSupernus Pharma 10-K, 10-Q, 8-K Forms - Stock Titan

Jul 22, 2025

Jul 22, 2025

Supernus Pharmaceuticals to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 5, 2025 - Stock Titan

Jul 22, 2025

Jul 22, 2025

What drives Supernus Pharmaceuticals Inc. stock priceExtraordinary performance - jammulinksnews.com

Jul 22, 2025

Jul 19, 2025

Supernus Pharmaceuticals Faces 3.2% Share Decline: Sector Challenges ImpactNews and Statistics - IndexBox

Jul 19, 2025

Jul 18, 2025

(SUPN) Investment Report - news.stocktradersdaily.com

Jul 18, 2025

Jul 18, 2025

Why Supernus Pharmaceuticals (SUPN) Shares Are Falling Today - Yahoo Finance

Jul 18, 2025

Jul 18, 2025

Is Supernus Pharmaceuticals Inc. stock a growth or value playQuick Profit Idea Stream - Newser

Jul 18, 2025

Jul 17, 2025

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Holdings Lowered by Teacher Retirement System of Texas - Defense World

Jul 17, 2025

Jul 15, 2025

Why Supernus Pharmaceuticals Inc. stock attracts strong analyst attentionTop Rated Trade Entries - Newser

Jul 15, 2025

Jul 15, 2025

How Supernus Pharmaceuticals Inc. stock performs during market volatilityStrong Buy Recommendations - Newser

Jul 15, 2025

Jul 15, 2025

What makes Supernus Pharmaceuticals Inc. stock price move sharplyFree Stock Market Expert Consultation - Newser

Jul 15, 2025

Jul 15, 2025

Principal Financial Group Inc. Boosts Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Jul 15, 2025

Jul 11, 2025

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Sold by Amalgamated Bank - Defense World

Jul 11, 2025

Jul 10, 2025

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Sold by Allspring Global Investments Holdings LLC - Defense World

Jul 10, 2025

Jul 08, 2025

When the Price of (SUPN) Talks, People Listen - news.stocktradersdaily.com

Jul 08, 2025

Jul 02, 2025

Supernus Pharmaceuticals to Acquire Sage Therapeutics in Transaction Valued Up to $795 Million - Global Legal Chronicle

Jul 02, 2025

Jun 30, 2025

Busy Philipps, Jay Glazer highlight ADHD experiences in Supernus’ campaigns - Medical Marketing and Media

Jun 30, 2025

Jun 27, 2025

Sage Therapeutics cuts over 300 jobs after securing buyer - The Business Journals

Jun 27, 2025

Jun 23, 2025

Supernus Pharmaceuticals (NASDAQ:SUPN) shareholders have earned a 6.8% CAGR over the last five years - Yahoo Finance

Jun 23, 2025

Jun 18, 2025

Supernus to acquire Sage Therapeutics stock for $8.50 per share By Investing.com - Investing.com UK

Jun 18, 2025

Jun 18, 2025

Supernus to acquire depression drugmaker Sage - MSN

Jun 18, 2025

Jun 18, 2025

Apomorphine Delivery Device Market Set to Witness Significant - openPR.com

Jun 18, 2025

Jun 17, 2025

Supernus Pharmaceuticals Gets Retail Excited Over $795M Acquisition Plan For Sage Therapeutics - MSN

Jun 17, 2025

Jun 17, 2025

Supernus Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks

Jun 17, 2025

Jun 17, 2025

SAGE to be Acquired by Supernus Pharmaceuticals in $795 Million Deal - Yahoo Finance

Jun 17, 2025

Jun 17, 2025

These Analysts Revise Their Forecasts On Sage Therapeutics Following Acquisition News - Benzinga

Jun 17, 2025

Jun 17, 2025

Supernus buys Sage Therapeutics for $561 million as Cantor holds rating - Investing.com Canada

Jun 17, 2025

Jun 17, 2025

Morning Movers: Sage Therapeutics surges after deal to be acquired by Supernus - Yahoo Finance

Jun 17, 2025

Jun 17, 2025

Are Supernus Pharmaceuticals, Inc.'s (NASDAQ:SUPN) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market? - simplywall.st

Jun 17, 2025